Associated Papers
Integrating epidemiology and genomics data to estimate the prevalence of acquired cysteine drug targets in the U.S. cancer patient population.
Arun AS et al.
The Pharmacogenomics Journal, 2025
40044654 (PubMed )
Supplement: 41397_2025_364_MOESM3_ESM.xlsx › Sheet1
Tumor genetic heterogeneity analysis of chronic sun-damaged melanoma.
Sanna A et al.
Pigment Cell & Melanoma Research, 2020
31811783 (PubMed )
Supplement: PCMR-33-480-s003.xls › Supplementary_Table_3
The Immunogenic Potential of Recurrent Cancer Drug Resistance Mutations: An In Silico Study.
Punta M et al.
Frontiers in Immunology, 2020
33133066 (PubMed )
Supplement: Table_1.xlsx › Passengers
Select a paper to view details